{"page_number": 287, "text_content": "1.3 The entity shall calculate the percentages of hazardous pharmaceutical waste by their final disposition method as the total weight of hazardous pharmaceutical waste generated that was (a) incinerated, (b) recycled/ treated, and (c) landfilled, divided by the total weight of hazardous pharmaceutical waste generated.\n\n1.3.1 Recycling or treatment shall include disposal via recycling facility, treatment facility, or other (e.g., return to a supplier or commercial composting).\n\n1.4 The entity may use the U.S. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA) or the EU Waste Framework Directive (Directive 2008/98/EC on waste, including its subsequent amendments) for the purposes of defining hazardous pharmaceutical waste for operations located in jurisdictions that lack applicable legal or regulatory definitions.\n\n1.5 The entity shall disclose the applicable jurisdictional standard or regulation used to define hazardous pharmaceutical waste.\n\n2 The entity shall disclose (2) the total amount of non-hazardous pharmaceutical waste generated, in metric tons, aggregated for all facilities it owns and operates, and the percentage (a) incinerated, (b) recycled or treated, and (c) landfilled.\n\n2.1 Non-hazardous (solid) waste is defined as any garbage or refuse, sludge from a wastewater treatment plant, water supply treatment plant, or air pollution control facility and other discarded material, including solid, liquid, semi-solid, or contained gaseous material resulting from industrial, commercial, mining, and agricultural operations, and from community activities. It may require special handling because it is a controlled substance or poses an environmental or human health effect.\n\n2.2 The entity shall calculate the percentages of non-hazardous pharmaceutical waste by their final disposition method as the total weight of non-hazardous pharmaceutical waste generated that was (a) incinerated, (b) recycled/treated, and (c) landfilled, divided by the total weight of non-hazardous pharmaceutical waste generated.\n\n2.2.1 Recycling or treatment shall include disposal via recycling facility, treatment facility, or other (e.g., return to a supplier or commercial composting).\n\n3 If there are other disposition methods for hazardous or non-hazardous pharmaceutical waste (e.g., composting or permanent long-term storage), then the entity should disclose these.\n\n4 If the entity utilizes a waste transport service, broker, or intermediary to handle its pharmaceutical waste, it shall make a good faith effort to determine the final disposition method."}